These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 17310638)
21. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease. Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J; Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870 [TBL] [Abstract][Full Text] [Related]
22. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease. Glas J; Török HP; Tonenchi L; Wetzke M; Beynon V; Teshome MY; Cotofana S; Schiemann U; Griga T; Klein W; Epplen JT; Folwaczny C; Folwaczny M; Mussack T; Weiss EH Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213 [TBL] [Abstract][Full Text] [Related]
23. The G2964A polymorphism of the STAT6 gene in inflammatory bowel disease. Klein W; Tromm A; Folwaczny C; Hagedorn M; Duerig N; Epplen J; Schmiegel W; Griga T Dig Liver Dis; 2005 Mar; 37(3):159-61. PubMed ID: 15888279 [TBL] [Abstract][Full Text] [Related]
24. Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population. Marrakchi R; Moussa A; Ouerhani S; Bougatef K; Bouhaha R; Messai Y; Rouissi K; Khadimallah I; Khodjet-el-Khil H; Najar T; Benammar-Elgaaeid A Inflamm Res; 2009 Mar; 58(3):155-60. PubMed ID: 19184348 [TBL] [Abstract][Full Text] [Related]
25. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease. Ozen SC; Dagli U; Kiliç MY; Törüner M; Celik Y; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM J Gastroenterol; 2006 Apr; 41(4):304-10. PubMed ID: 16741608 [TBL] [Abstract][Full Text] [Related]
26. [Haptoglobin polymorphism in patients with inflammatory bowel diseases]. Papp M; Lakatos PL; ; Palatka K; Földi I; Udvardy M; Hársfalvi J; Tornai I; Vitális Z; Dinya T; Kovács A; Molnár T; Demeter P; Papp J; Lakatos L; Altorjay I Orv Hetil; 2006 Sep; 147(36):1745-50. PubMed ID: 17087019 [TBL] [Abstract][Full Text] [Related]
27. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129 [TBL] [Abstract][Full Text] [Related]
29. The genetics and immunopathogenesis of inflammatory bowel disease. Cho JH Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230 [TBL] [Abstract][Full Text] [Related]
30. Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16. Cavanaugh JA; Callen DF; Wilson SR; Stanford PM; Sraml ME; Gorska M; Crawford J; Whitmore SA; Shlegel C; Foote S; Kohonen-Corish M; Pavli P Ann Hum Genet; 1998 Jul; 62(Pt 4):291-8. PubMed ID: 9924607 [TBL] [Abstract][Full Text] [Related]
31. Advances in the molecular dissection of inflammatory bowel disease. Siminovitch KA Semin Immunol; 2006 Aug; 18(4):244-53. PubMed ID: 16679026 [TBL] [Abstract][Full Text] [Related]
32. Inflammatory bowel disease: Crohn's disease and the success of NODern genetics. Newman B; Siminovitch K Clin Invest Med; 2003 Dec; 26(6):303-14. PubMed ID: 14690304 [TBL] [Abstract][Full Text] [Related]
33. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. McGovern DP; Hysi P; Ahmad T; van Heel DA; Moffatt MF; Carey A; Cookson WO; Jewell DP Hum Mol Genet; 2005 May; 14(10):1245-50. PubMed ID: 15790594 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease. Papa A; Pola R; Flex A; Danese S; Armuzzi A; Gaetani E; Guidi L; De Vitis I; Urgesi R; Grillo A; Serricchio M; Proia AS; Fedeli G; Gasbarrini G; Pola P; Gasbarrini A Dig Liver Dis; 2004 Aug; 36(8):528-32. PubMed ID: 15334773 [TBL] [Abstract][Full Text] [Related]
35. Genetics of inflammatory bowel disease. Karban A; Eliakim R; Brant SR Isr Med Assoc J; 2002 Oct; 4(10):798-802. PubMed ID: 12389344 [TBL] [Abstract][Full Text] [Related]
36. Clinical applications of advances in the genetics of IBD. Sartor RB Rev Gastroenterol Disord; 2003; 3 Suppl 1():S9-17. PubMed ID: 12684584 [TBL] [Abstract][Full Text] [Related]
37. Association of a CXCL9 polymorphism with pediatric Crohn's disease. Lacher M; Kappler R; Berkholz S; Baurecht H; von Schweinitz D; Koletzko S Biochem Biophys Res Commun; 2007 Nov; 363(3):701-7. PubMed ID: 17892861 [TBL] [Abstract][Full Text] [Related]
38. [Does smoking influence the course of Crohn's disease in patients with the presence of gene NOD2/CARD15 mutation?]. Dobrowolska-Zachwieja A; Kaczmarek M; Hoppe-Gołebiewska J; Kalak R; Słomski R; Linke K Pol Merkur Lekarski; 2005 May; 18(107):560-5. PubMed ID: 16161956 [TBL] [Abstract][Full Text] [Related]
39. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease. Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779 [TBL] [Abstract][Full Text] [Related]
40. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis. Agius LM J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]